跳至主要内容
临床试验/JPRN-UMIN000004092
JPRN-UMIN000004092招募中2 期

The randomized controlled trial of the THP-COP therapy versus CHOP therapy for T-cell lymphoma with or without P-glycoprotein expression - The randomized controlled trial of the THP-COP therapy versus CHOP therapy for T-cell lymphoma with or without P-glycoprotein expression (OLSG10-01 clinical trial)

Osaka Lymphoma Study Group0 个研究点目标入组 94 人开始时间: 2010年8月24日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
94

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Previously treated patients 2)Other active multiple cancers 3)Severe complications (liver, kidney, cardiac disease, infection, etc) 4)Severe cardiac disfunction 5)History of angina pectoris, myocardial infarction 6)pregnant women and women suspected to be pregnant 7)HBV carrier (hepatitis B surface antigen positivity, HBc antibody positive or HBs antibody positivity), HCV positivity 8)HTLV-1 positivity 9)HIV positivity 10)History of severe drug hypersensitivity 11)judged to be inappropriate for other reasons by physician

研究者

发起方
Osaka Lymphoma Study Group

相似试验

The randomized controlled trial of the THP-COP... | 临床试验